Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
611 in Chinese Children With Moderate to Severe Atopic Dermatitis
NCT07767253Phase 3Recruiting
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 3 trial of SSGJ-611 in atopic dermatitis (AD), sponsored by 3S Guojian Pharmaceutical. Started Sep 2026; status: recruiting.
02
Drugs
SSGJ-611
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07767253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07767253.